August 23, 2007

VIA EDGAR AND FACSIMILE

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549-3561

Re:    Form S-3 Registration No. 333-144155
       Application for Withdrawal Pursuant to Rule 477


Ladies and Gentlemen:

     Pursuant to Rule 477 of the Securities Act of 1933, as amended,  Integrated
BioPharma,  Inc. (the "Company") respectfully requests and hereby applies for an
order from the staff of the Division of  Corporation  Finance of the  Securities
and Exchange Commission (the "Commission")  granting the immediate withdrawal of
the Company's  registration statement on Form S-3 and all exhibits thereto (File
No.  333-144155),  filed  with  the  Commission  on June 28,  2007 and  declared
effective by the  Commission  on July 11, 2007 (the  "Registration  Statement").

Withdrawal  of the  Registration  Statement  is  requested  because  the selling
stockholders  listed therein do not at this time plan to sell  securities of the
Company as contemplated by the Registration  Statement.  No securities were sold
pursuant to the prospectus included in the Registration  Statement.

If you have any  questions  regarding  this matter,  please  contact our
counsel,  Andrew H. Abramowitz, Esq. of Greenberg Traurig, LLP, at
(212) 801-6752.

                                      Very truly yours,

                                      NTEGRATED BIOPHARMA, INC.


                                      By: /s/ Dina L. Masi
                                      Dina L. Masi
                                      Title:  Chief Financial Officer

cc: Andrew H. Abramowitz